| 1 |
pH-responsive antibodies for therapeutic applications
Tomasz Klaus, Sameer Deshmukh · Journal of Biomedical Science
Open access |
22 Jan 2021 |
64 |
| 2 |
Integrin Alpha v Beta 6 (αvβ6) and Its Implications in Cancer Treatment
Ewa Brzozowska, Sameer S. Deshmukh · International Journal of Molecular Sciences
Open access |
15 Oct 2022 |
50 |
| 3 |
A dual transacylation mechanism for polyketide synthase chain release in enacyloxin antibiotic biosynthesis
Joleen Masschelein, Paulina K. Sydor, Christian Hobson et al. · Nature Chemistry
Open access |
23 Sep 2019 |
43 |
| 4 |
Phages in Therapy and Prophylaxis of American Foulbrood – Recent Implications From Practical Applications
Ewa Jończyk‐Matysiak, Ewa Popiela, Barbara Owczarek et al. · Frontiers in Microbiology
Open access |
11 Aug 2020 |
25 |
| 5 |
Inhibition of HCK in myeloid cells restricts pancreatic tumor growth and metastasis
Ashleigh R. Poh, Megan A. O’Brien, David Chisanga et al. · Cell Reports
Open access |
Oct 2022 |
21 |
| 6 |
Isolation and Characterization of Phages Active against Paenibacillus larvae Causing American Foulbrood in Honeybees in Poland
Ewa Jończyk‐Matysiak et al. · Viruses
Open access |
23 Jun 2021 |
21 |
| 7 |
A Conjugate Based on Anti-HER2 Diaffibody and Auristatin E Targets HER2-Positive Cancer Cells
Anna M. Serwotka-Suszczak, Alicja M. Sochaj-Gregorczyk, Jerzy Pieczykolan et al. · International Journal of Molecular Sciences
Open access |
14 Feb 2017 |
18 |
| 8 |
A deep intronic splice–altering AIRE variant causes APECED syndrome through antisense oligonucleotide-targetable pseudoexon inclusion
Sebastian Ochoa et al. · Science Translational Medicine
Open access |
18 Sep 2024 |
16 |
| 9 |
LAP: Liability Antibody Profiler by sequence & structural mapping of natural and therapeutic antibodies
Tadeusz Satława, Mateusz Tarkowski, Sonia Wróbel et al. · PLoS Computational Biology
Open access |
5 Mar 2024 |
12 |
| 10 |
Benchmarking antibody clustering methods using sequence, structural, and machine learning similarity measures for antibody discovery applications
Dawid Chomicz, Jarosław Kończak, Sonia Wróbel et al. · Frontiers in Molecular Biosciences
Open access |
28 Mar 2024 |
10 |
| 11 |
Trabectedin promotes oncolytic virus antitumor efficacy, viral gene expression, and immune effector function in models of bone sarcoma
Emily M. Ringwalt, Mark A. Currier, Andrea M. Glaspell et al. · Molecular Therapy Oncology
Open access |
26 Sep 2024 |
8 |
| 12 |
Secretome of brain microvascular endothelial cells promotes endothelial barrier tightness and protects against hypoxia-induced vascular leakage
Rodrigo Azevedo Loiola, Johan Hachani, Sophie Duban‐Deweer et al. · Molecular Medicine
Open access |
26 Aug 2024 |
7 |
| 13 |
Vaccination with DC-SIGN-Targeting αGC Liposomes Leads to Tumor Control, Irrespective of Suboptimally Activated T-Cells
Aram M. de Haas, Dorian A. Stolk, Sjoerd T. T. Schetters et al. · Pharmaceutics
Open access |
24 Apr 2024 |
5 |
| 14 |
Multi-Epitope DC Vaccines with Melanoma Antigens for Immunotherapy of Melanoma
Athanasios Seretis, Lukas Amon, Christoph H. Tripp et al. · Vaccines
Open access |
25 Mar 2025 |
4 |
| 15 |
Synthetic High‐Throughput Microarrays of Peptidoglycan Fragments as a Novel Sero‐Diagnostic Tool for Patient Antibody Profiling
Alexandra Tsouka, Yanyan Fu, Manuel G. Ricardo et al. · Angewandte Chemie International Edition
Open access |
13 Feb 2025 |
4 |
| 16 |
Mouse IgG3 binding to macrophage-like cells is prevented by deglycosylation of the antibody or by Accutase treatment of the cells
Alicja Karabasz, Monika Bzowska, Joanna Bereta et al. · Scientific Reports
Open access |
13 May 2021 |
4 |
| 17 |
IL-10 Plays a Critical Role in Mitigating Acute Anaemia Development During African Trypanosome Infection
Maida Živalj, Anaïs St. Martin, Patrick De Baetselier et al. · Pathogens
Open access |
12 Dec 2025 |
2 |
| 18 |
A novel fully human anti-ROR1 antibody PBA-0405 optimized for ADCC, induces potent anti-tumor activity against both solid and hematological malignancies
Niina Veitonmäki et al. · Frontiers in Immunology
Open access |
17 Dec 2025 |
2 |
| 19 |
Insights into In Vitro Adaptation of EV71 and Analysis of Reduced Virulence by In Silico Predictions
Jia Xuen Koh, Malihe Masomian, Mohd Ishtiaq Anasir et al. · Vaccines
Open access |
11 Mar 2023 |
2 |
| 20 |
Pure Biologics – From a Bootstrapped Boutique CRO to an Integrated Drug Discovery Public Company
Sameer Deshmukh, Przemysław Jurek, Filip Jeleń et al. · Technology Transfer and Entrepreneurship
|
13 Mar 2020 |
2 |
| 21 |
The crystal structure of PD1, aHaemophilussurface fibril domain
Jack Wright, Maren Thomsen, R. Kolodziejczyk et al. · Acta Crystallographica Section F Structural Biology Communications
Open access |
31 Jan 2017 |
2 |
| 22 |
Preparation of Chemically Modified DNA Library for SELEX via Incorporation of CLB-dUTP in Primer Extension Reaction
Magda Puchała, Marta Radzińska, Joanna Guzdek et al. · Methods in molecular biology
Book chapter |
26 Sep 2022 |
1 |
| 23 |
A fully human afucosylated anti-GARP antibody PBA-0111 drives anti-tumor immunity through combined ADCC induction and TGF-β1 pathway blockade
Pieter Spee et al. · Frontiers in Immunology
Open access |
17 Sep 2026 |
0 |
| 24 |
Anti-Dengue Activity of Revaprazan Hydrochloride: A Repurposed Drug Candidate
Shobana Gabriel, Malihe Masomian, Chit Laa Poh et al. · Progress In Microbes & Molecular Biology
Open access |
9 Jul 2025 |
0 |
| 25 |
Synthetische Hochdurchsatz‐Mikroarrays von Peptidoglykan Fragmenten als neuartiges serodiagnostisches Instrument zur Erstellung von Antikörperprofilen bei Patienten
Alexandra Tsouka, Yanyan Fu, Manuel G. Ricardo et al. · Angewandte Chemie
Open access |
13 Feb 2025 |
0 |
| 26 |
PD-L1 blockade immunotherapy rewires cancer emergency myelopoiesis
Athina Boumpas, Antonis Papaioannou, Pavlos Bousounis et al. · bioRxiv (Cold Spring Harbor Laboratory)
PreprintOpen access |
21 Dec 2023 |
0 |